Orchestra BioMed Holdings, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-11-10: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2025-08-12: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2025-05-12: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2025-03-31: Form 10-K; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-11-10 | 10-Q | Emerging growth company | Yes |
| 2025-08-12 | 10-Q | Emerging growth company | Yes |
| 2025-05-12 | 10-Q | Emerging growth company | Yes |
| 2025-03-31 | 10-K | Emerging growth company | Yes |
| 2024-11-12 | 10-Q | Emerging growth company | Yes |
| 2024-08-12 | 10-Q | Emerging growth company | Yes |
| 2024-05-13 | 10-Q | Emerging growth company | Yes |
| 2024-03-27 | 10-K | Emerging growth company | Yes |
| 2023-11-13 | 10-Q | Emerging growth company | Yes |
| 2023-08-10 | 10-Q | Emerging growth company | Yes |
| 2023-05-12 | 10-Q | Emerging growth company | Yes |
| 2023-01-25 | 10-K | Stock registered under Section 12(b) | Ordinary Shares, par value $0.0001 per share · HSAQ · NASDAQ |
| 2023-01-25 | 10-K | Shell company | Yes |
| 2023-01-25 | 10-K | Emerging growth company | Yes |
| 2022-11-14 | 10-Q | Stock registered under Section 12(b) | Ordinary Shares · HSAQ · NASDAQ |
| 2022-11-14 | 10-Q | Shell company | Yes |
| 2022-11-14 | 10-Q | Emerging growth company | Yes |
| 2022-08-15 | 10-Q | Stock registered under Section 12(b) | Ordinary Shares · HSAQ · NASDAQ |
| 2022-08-15 | 10-Q | Shell company | Yes |
| 2022-08-15 | 10-Q | Emerging growth company | Yes |
| 2022-05-13 | 10-Q | Stock registered under Section 12(b) | Ordinary Shares · HSAQ · NASDAQ |
| 2022-05-13 | 10-Q | Shell company | Yes |
| 2022-05-13 | 10-Q | Emerging growth company | Yes |
| 2022-03-31 | 10-Q/A | Stock registered under Section 12(b) | Ordinary Shares · HSAQ · NASDAQ |
| 2022-03-31 | 10-K | Stock registered under Section 12(b) | Ordinary Shares, par value $0.0001 per share · HSAQ · NASDAQ |
| 2022-03-31 | 10-Q/A | Shell company | Yes |
| 2022-03-31 | 10-K | Shell company | Yes |
| 2022-03-31 | 10-K/A | Shell company | Yes |
| 2022-03-31 | 10-Q/A | Emerging growth company | Yes |
| 2022-03-31 | 10-K | Emerging growth company | Yes |
| 2022-03-31 | 10-K/A | Emerging growth company | Yes |
| 2022-03-31 | 10-K/A | Current in its reporting | No |
| 2021-11-12 | 10-Q | Stock registered under Section 12(b) | Ordinary Shares · HSAQ · NASDAQ |
| 2021-11-12 | 10-Q | Shell company | Yes |
| 2021-11-12 | 10-Q | Emerging growth company | Yes |
| 2021-08-16 | 10-Q | Stock registered under Section 12(b) | Ordinary Shares · HSAQ · NASDAQ |
| 2021-08-16 | 10-Q | Shell company | Yes |
| 2021-08-16 | 10-Q | Emerging growth company | Yes |
| 2021-05-17 | 10-Q | Shell company | Yes |
| 2021-05-17 | 10-Q | Emerging growth company | Yes |
| 2021-03-10 | 10-K | Shell company | Yes |
| 2021-03-10 | 10-K | Emerging growth company | Yes |
| 2020-11-05 | 10-Q | Shell company | Yes |
| 2020-11-05 | 10-Q | Emerging growth company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |